BrightHeart announced that it received FDA 510(k) clearance for its first AI software for prenatal ultrasound evaluations of ...

Rhythm Technologies announced new research emphasizing the clinical and health-economic advantages of its Zio LTCM system.

Zimmer Biomet (NYSE:ZBH) announced today that it received CE mark approval in Europe for its Persona revision knee system.

Boston Scientific (NYSE:BSX) announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX ...

Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.